retatrutide triple agonist weight loss trial Lilly's phase 3 results: 28.3% body on highest dose Retatrutide Strengthens Position in Obesity

A weight management stack like CagriSema pairs amylin and GLP-1 signaling, while Retatrutide + MOTS-c pairs triple-agonist appetite and energy signaling with mitochondrial support for broader metabolic coverage

Toth PP

Hormone and Metabolic Research , 36(1112), 735741

By simultaneously aiming at GLP-1, GIP, and glucagon receptors, these drugs, such as retatrutide, deliver significantly greater efficacy than current therapies, expanding the addressable patient base

Tyna: Oh, that breaks my heart

Monthly cash costs vary by brand, dose, formulation, and whether you use an FDA-approved product or a compounded alternative